News
In subgroup analyses, increases in discontinuation of inhaled steroid therapy were greater among kids ages 5 years and ...
Eupraxia’s CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback